{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:07:38Z","timestamp":1791295658392,"version":"4.1.0"},"reference-count":157,"publisher":"Elsevier","isbn-type":[{"value":"9780444642080","type":"print"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/bs.pbr.2019.03.013","type":"book-chapter","created":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T18:47:43Z","timestamp":1554230863000},"page":"119-144","source":"Crossref","is-referenced-by-count":65,"title":["Oligodendrocyte precursor cells as a therapeutic target for demyelinating diseases"],"prefix":"10.1016","author":[{"given":"Stephen D.","family":"Skaper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.pbr.2019.03.013_bb0010","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1523\/JNEUROSCI.3510-14.2015","article-title":"Anti-muscarinic adjunct therapy accelerates functional human oligodendrocyte repair","volume":"35","author":"Abiraman","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0015","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.drudis.2014.06.007","article-title":"Harnessing the anti-inflammatory potential of palmitoylethanolamide","volume":"19","author":"Alhouayek","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0020","first-page":"325061","article-title":"Beneficial effects of palmitoylethanolamide on expressive language, cognition, and behaviors in autism: a report of two cases","volume":"2015","author":"Antonucci","year":"2015","journal-title":"Case Rep. Psychiatry"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0025","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1126\/science.1103709","article-title":"bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS","volume":"306","author":"Arnett","year":"2004","journal-title":"Science"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0030","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/bph.12263","article-title":"Antagonism of histamine H4 receptors exacerbates clinical and pathological signs of experimental autoimmune encephalomyelitis","volume":"170","author":"Ballerini","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0035","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s12264-013-1321-3","article-title":"Oligodendroglia and neurotrophic factors in neurodegeneration","volume":"29","author":"Bankston","year":"2013","journal-title":"Neurosci. Bull."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0040","doi-asserted-by":"crossref","first-page":"16676","DOI":"10.1038\/srep16676","article-title":"Co-ultramicronized palmitoylethanolamide\/luteolin promotes the maturation of oligodendrocyte precursor cells","volume":"5","author":"Barbierato","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0045","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1152\/physrev.2001.81.2.871","article-title":"Biology of oligodendrocyte and myelin in the mammalian central nervous system","volume":"81","author":"Baumann","year":"2001","journal-title":"Physiol. Rev."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0050","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.nicl.2017.11.002","article-title":"Gray matter atrophy patterns in multiple sclerosis: a 10-year source-based morphometry study. 2017","volume":"17","author":"Bergsland","year":"2017","journal-title":"Neuroimage Clin."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0055","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/cns.12648","article-title":"Beneficial effects of co-ultramicronized palmitoylethanolamide\/luteolin in a mouse model of autism and in a case report of autism","volume":"23","author":"Bertolino","year":"2017","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0060","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.4049\/jimmunol.1003511","article-title":"Glycogen synthase kinase-3 is an early determinant in the differentiation of pathogenic Th17 cells","volume":"186","author":"Beurel","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0065","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.4049\/jimmunol.1203057","article-title":"Regulation of Th1 cells and experimental autoimmune encephalomyelitis by glycogen synthase kinase-3","volume":"190","author":"Beurel","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0070","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0378-5173(88)90235-9","article-title":"Physicochemical aspects of drug release. VIII. The relation between particle size and surface specific dissolution rate in agitated suspensions","volume":"47","author":"Bisrat","year":"1988","journal-title":"Int. J. Pharm."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0075","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/ana.24620","article-title":"Dynamic imaging of individual remyelination profiles in multiple sclerosis","volume":"79","author":"Bodini","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0080","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00401-013-1112-y","article-title":"Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models","volume":"125","author":"Boyd","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0085","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1093\/brain\/awq250","article-title":"Demyelination versus remyelination in progressive multiple sclerosis","volume":"133","author":"Bramow","year":"2010","journal-title":"Brain"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0301-0082(03)00002-9","article-title":"Roles of the mammalian subventricular zone in brain development","volume":"69","author":"Brazel","year":"2003","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0095","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2174\/1871527316666170321124949","article-title":"Ultra-micronized palmitoylethanolamide: an efficacious adjuvant therapy for Parkinson's disease","volume":"16","author":"Brotini","year":"2017","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0100","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nri3362","article-title":"The resolution of inflammation","volume":"13","author":"Buckley","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0105","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s12975-015-0440-8","article-title":"Co-ultramicronized palmitoylethanolamide\/luteolin in the treatment of cerebral ischemia: from rodent to man","volume":"7","author":"Caltagirone","year":"2016","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0110","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.powtec.2016.09.084","article-title":"Palmitoylethanolamide sub-micronization using fast precipitation followed by supercritical fluids extraction","volume":"305","author":"Campardelli","year":"2017","journal-title":"Powder Technol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0115","doi-asserted-by":"crossref","first-page":"6404","DOI":"10.1523\/JNEUROSCI.20-17-06404.2000","article-title":"NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions","volume":"20","author":"Chang","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0120","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1056\/NEJMoa010994","article-title":"Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis","volume":"346","author":"Chang","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0125","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/ana.23693","article-title":"Cortical remyelination: a new target for repair therapies in multiple sclerosis","volume":"72","author":"Chang","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0130","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/brain\/awf025","article-title":"Brain atrophy in clinically early relapsing-remitting multiple sclerosis","volume":"125","author":"Chard","year":"2002","journal-title":"Brain"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0135","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1358\/mf.1998.20.3.485666","article-title":"Micronization: a method of improving the bioavailability of poorly soluble drugs","volume":"20","author":"Chaumeil","year":"1998","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0140","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.neuroscience.2014.08.011","article-title":"Inflammation triggers production of dimethylsphingosine from oligodendrocytes","volume":"279","author":"Chen","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0145","first-page":"578","article-title":"Advances in the pharmacological activities and mechanisms of diosgenin","volume":"13","author":"Chen","year":"2015","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189380","article-title":"Histamine receptor 3 negatively regulates oligodendrocyte differentiation and remyelination","volume":"12","author":"Chen","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0155","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2174\/1871527311201070933","article-title":"Amyotrophic lateral sclerosis treatment with ultramicronized palmitoylethanolamide: a case report","volume":"11","author":"Clemente","year":"2012","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0160","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0165","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1089\/neu.2014.3460","article-title":"Neuroprotective effects of co-ultraPEALut on secondary inflammatory process and autophagy involved in traumatic brain injury","volume":"33","author":"Cordaro","year":"2016","journal-title":"J. Neurotrauma"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0170","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/384083a0","article-title":"Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides","volume":"384","author":"Cravatt","year":"1996","journal-title":"Nature"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0175","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fphar.2016.00047","article-title":"Co-ultramicronized palmitoylethanolamide\/luteolin promotes neuronal regeneration after spinal cord injury","volume":"7","author":"Crupi","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/bs.pbr.2019.03.013_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096193","article-title":"The clinical impact of cerebellar grey matter pathology in multiple sclerosis","volume":"9","author":"Damasceno","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0185","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/dneu.20976","article-title":"Muscarinic receptor subtypes as potential targets to modulate oligodendrocyte progenitor survival, proliferation, and differentiation","volume":"72","author":"De Angelis","year":"2012","journal-title":"Dev. Neurobiol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0190","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1083\/jcb.201505119","article-title":"Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation","volume":"211","author":"de la Fuente","year":"2015","journal-title":"J. Cell Biol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0195","doi-asserted-by":"crossref","first-page":"541","DOI":"10.4049\/jimmunol.1101498","article-title":"Histamine H4 receptor optimizes T regulatory cell frequency and facilitates anti-inflammatory responses within the central nervous system","volume":"188","author":"del Rio","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0200","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature12647","article-title":"A regenerative approach to the treatment of multiple sclerosis","volume":"502","author":"Deshmukh","year":"2013","journal-title":"Nature"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0205","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10571-009-9486-z","article-title":"Age-related and cuprizone-induced changes in myelin and transcription factor gene expression and in oligodendrocyte cell densities in the rostral corpus callosum of mice","volume":"30","author":"Doucette","year":"2010","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0210","doi-asserted-by":"crossref","first-page":"11120","DOI":"10.1038\/ncomms11120","article-title":"Kappa opioid receptor activation alleviates experimental autoimmune encephalomyelitis and promotes oligodendrocyte-mediated remyelination","volume":"7","author":"Du","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0215","doi-asserted-by":"crossref","first-page":"10967","DOI":"10.1523\/JNEUROSCI.2572-06.2006","article-title":"Functional genomic analysis of oligodendrocyte differentiation","volume":"26","author":"Dugas","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0220","doi-asserted-by":"crossref","first-page":"7267","DOI":"10.1523\/JNEUROSCI.17-19-07267.1997","article-title":"Conduction in segmentally demyelinated mammalian central axons","volume":"17","author":"Felts","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0225","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.2174\/0929867321666140303143455","article-title":"Neuroprotective properties of peroxisome proliferator-activated receptor alpha (PPAR\u03b1) and its lipid ligands","volume":"21","author":"Fidaleo","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0230","article-title":"Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis","volume":"6","author":"Filippini","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0235","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4137\/PMC.S13213","article-title":"Multiple sclerosis: overview of disease-modifying agents","volume":"6","author":"Finkelsztejn","year":"2014","journal-title":"Perspect. Medicin. Chem."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0240","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nrn.2017.136","article-title":"Regenerating CNS myelin\u2014from mechanisms to experimental medicines","volume":"18","author":"Franklin","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0245","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.autrev.2014.07.002","article-title":"Targets of the humoral autoimmune response in multiple sclerosis","volume":"13","author":"Fraussen","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0250","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nature11007","article-title":"Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity","volume":"485","author":"F\u00fcnfschilling","year":"2012","journal-title":"Nature"},{"issue":"72","key":"10.1016\/bs.pbr.2019.03.013_bb0255","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1212\/WNL.0b013e3181a8260a","article-title":"Remyelination capacity of the MS brain decreases with disease chronicity","volume":"2009","author":"Goldschmidt","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0260","doi-asserted-by":"crossref","first-page":"31599","DOI":"10.1038\/srep31599","article-title":"Tamoxifen accelerates the repair of demyelinated lesions in the central nervous system","volume":"6","author":"Gonzalez","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0265","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1006\/mcne.1996.0033","article-title":"Overexpression of 2\u2032,3\u2032-cyclic nucleotide 3\u2032-phosphodiesterase in transgenic mice alters oligodendrocyte development and produces aberrant myelination","volume":"7","author":"Gravel","year":"1996","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0270","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2990.1995.tb01034.x","article-title":"The proteolipid protein gene","volume":"21","author":"Griffiths","year":"1995","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0275","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/jnen\/61.4.297","article-title":"Cells and signaling in oligodendrocyte development","volume":"61","author":"Grinspan","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0280","doi-asserted-by":"crossref","first-page":"5472","DOI":"10.1038\/ncomms6472","article-title":"Oligodendrocyte ablation triggers central pain independently of innate or adaptive immune responses in mice","volume":"5","author":"Gritsch","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0285","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/glia.22281","article-title":"Erk1\/2 MAPK and mTOR signaling sequentially regulates progression through distinct stages of oligodendrocyte differentiation","volume":"60","author":"Guardiola-Diaz","year":"2012","journal-title":"Glia"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0290","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1523\/JNEUROSCI.4787-14.2015","article-title":"The Wnt effector transcription factor 7-like 2 positively regulates oligodendrocyte differentiation in a manner independent of Wnt\/\u03b2-catenin signaling","volume":"35","author":"Hammond","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0295","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.ajpath.2012.01.018","article-title":"Focal immune-mediated white matter demyelination reveals an age-associated increase in axonal vulnerability and decreased remyelination efficiency","volume":"180","author":"Hampton","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0300","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1016\/j.cub.2006.11.042","article-title":"Rapid conduction and the evolution of giant axons and myelinated fibers","volume":"17","author":"Hartline","year":"2007","journal-title":"Curr. Biol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0305","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/nrneurol.2017.2","article-title":"Immune-directed therapies in MS\u2014efficacy and limitations","volume":"13","author":"Hemmer","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0310","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nn.2702","article-title":"Retinoid X receptor gamma signaling accelerates CNS remyelination","volume":"14","author":"Huang","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0315","first-page":"437","article-title":"The discovery of oligodendroglia cells by Rio-Hortega: his original articles. 1921","volume":"31","author":"Iglesias-Rozas","year":"2012","journal-title":"Clin. Neuropathol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0320","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12974-014-0136-0","article-title":"Micronized\/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to non-micronized palmitoylethanolamide in a rat model of inflammatory pain","volume":"11","author":"Impellizzeri","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0325","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.tins.2016.04.003","article-title":"Activity-dependent and experience-driven myelination provide new directions for the management of multiple sclerosis","volume":"39","author":"Jensen","year":"2016","journal-title":"Trends Neurosci."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0330","first-page":"651","article-title":"A review on micronization techniques","volume":"3","author":"Joshi","year":"2011","journal-title":"J. Pharm. Sci. Technol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0335","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000360528","article-title":"Multiple sclerosis: current knowledge and future outlook","volume":"72","author":"Kamm","year":"2014","journal-title":"Eur. Neurol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0340","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1172\/JCI116875","article-title":"Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein","volume":"92","author":"Kerlero de Rosbo","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0345","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/brain\/122.1.17","article-title":"Cortical lesions in multiple sclerosis","volume":"122","author":"Kidd","year":"1999","journal-title":"Brain"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0350","doi-asserted-by":"crossref","first-page":"506","DOI":"10.2174\/187152712801661248","article-title":"Pathology of multiple sclerosis","volume":"11","author":"Kipp","year":"2012","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0355","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1042\/bj1860959","article-title":"UDP-galactose-ceramide galactosyltransferase in rat brain myelin subfractions during development","volume":"186","author":"Koul","year":"1980","journal-title":"Biochem. J."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0360","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/ana.22415","article-title":"The complex world of oligodendroglial differentiation inhibitors","volume":"69","author":"Kremer","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0365","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1093\/brain\/awn096","article-title":"Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis","volume":"131","author":"Kuhlmann","year":"2008","journal-title":"Brain"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0370","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.nbd.2013.04.005","article-title":"Estrogen receptor \u03b2 ligand therapy activates PI3K\/Akt\/mTOR signaling in oligodendrocytes and promotes remyelination in a mouse model of multiple sclerosis","volume":"56","author":"Kumar","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0375","doi-asserted-by":"crossref","first-page":"8432","DOI":"10.1523\/JNEUROSCI.1105-14.2014","article-title":"Balanced mTORC1 activity in oligodendrocytes is required for accurate CNS myelination","volume":"34","author":"Lebrun-Julien","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0380","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1083\/jcb.200411047","article-title":"Process outgrowth in oligodendrocytes is mediated by CNP, a novel microtubule assembly myelin protein","volume":"170","author":"Lee","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0385","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature11314","article-title":"Oligodendroglia metabolically support axons and contribute to neurodegeneration","volume":"487","author":"Lee","year":"2012","journal-title":"Nature"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0390","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3109\/03639045.2013.828217","article-title":"Recent advancements in mechanical reduction methods: particulate systems","volume":"40","author":"Leleux","year":"2014","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0395","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1021\/bi060163l","article-title":"Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids","volume":"45","author":"Leung","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0400","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0166-2236(00)01691-X","article-title":"The oligodendrocyte precursor cell in health and disease","volume":"24","author":"Levine","year":"2001","journal-title":"Trends Neurosci."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0405","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1124\/mol.104.006353","article-title":"The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide","volume":"67","author":"Lo Verme","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0410","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3389\/fncel.2017.00208","article-title":"Social isolation in early versus late adolescent mice is associated with persistent behavioral deficits that can be improved by neurosteroid-based treatment","volume":"11","author":"Locci","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0415","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.brainres.2015.10.051","article-title":"Oligodendrocyte progenitor programming and reprogramming: toward myelin regeneration","volume":"1638","author":"Lopez Juarez","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0420","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1056\/NEJMoa1100648","article-title":"Inflammatory cortical demyelination in early multiple sclerosis","volume":"365","author":"Lucchinetti","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0425","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1586\/14737175.2014.969241","article-title":"Remyelinating strategies in multiple sclerosis","volume":"14","author":"Luessi","year":"2014","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0430","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.brainres.2007.11.034","article-title":"Decreased spinal cord opioid receptor mRNA expression and antinociception in a Theiler's murine encephalomyelitis virus model of multiple sclerosis","volume":"1191","author":"Lynch","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0435","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1126\/science.1072810","article-title":"Identification of Bphs, an autoimmune disease locus, as histamine receptor H1","volume":"297","author":"Ma","year":"2002","journal-title":"Science"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0440","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3389\/fncel.2016.00027","article-title":"Systematic review of pharmacological properties of the oligodendrocyte lineage","volume":"10","author":"Marinelli","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0445","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.phrs.2014.05.006","article-title":"Palmitoylethanolamide in CNS health and disease","volume":"86","author":"Mattace Raso","year":"2014","journal-title":"Pharmacol. Res."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0450","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1007\/s00018-013-1340-2","article-title":"Inhibition of endogenous phosphodiesterase 7 promotes oligodendrocyte precursor differentiation and survival","volume":"70","author":"Medina-Rodr\u00edguez","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"issue":"7","key":"10.1016\/bs.pbr.2019.03.013_bb0455","doi-asserted-by":"crossref","first-page":"43545","DOI":"10.1038\/srep43545","article-title":"Promoting in vivo remyelination with small molecules: a neuroreparative pharmacological treatment for multiple sclerosis","volume":"3","author":"Medina-Rodr\u00edguez","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0460","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/nm.3618","article-title":"Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis","volume":"20","author":"Mei","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0465","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.18246.013","article-title":"Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery","author":"Mei","year":"2016","journal-title":"Elife"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0470","doi-asserted-by":"crossref","first-page":"7925","DOI":"10.1523\/JNEUROSCI.1493-16.2016","article-title":"Identification of the kappa-opioid receptor as a therapeutic target for oligodendrocyte remyelination","volume":"36","author":"Mei","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0475","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nn.3991","article-title":"Synaptic vesicle release regulates myelin sheath number of individual oligodendrocytes in vivo","volume":"18","author":"Mensch","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0480","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00004714-198910000-00006","article-title":"Dopaminergic activity of the antimuscarinic antiparkinsonian agents","volume":"9","author":"Modell","year":"1989","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0485","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.tcb.2013.07.007","article-title":"Oligodendroglia: metabolic supporters of axons","volume":"23","author":"Morrison","year":"2013","journal-title":"Trends Cell Biol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0490","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4049\/jimmunol.176.1.17","article-title":"A key regulatory role for histamine in experimental autoimmune encephalomyelitis: disease exacerbation in histidine decarboxylase-deficient mice","volume":"176","author":"Musio","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0495","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature14335","article-title":"Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo","volume":"522","author":"Najm","year":"2015","journal-title":"Nature"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0500","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nature09614","article-title":"Myelination and support of axonal integrity by glia","volume":"468","author":"Nave","year":"2010","journal-title":"Nature"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0505","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/glia.22364","article-title":"Phosphorylated olig1 localizes to the cytosol of oligodendrocytes and promotes membrane expansion and maturation","volume":"60","author":"Niu","year":"2012","journal-title":"Glia"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0510","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/BF02976347","article-title":"Effect of micronization on the extent of drug absorption from suspensions in humans","volume":"18","author":"Oh","year":"1995","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0515","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/jnr.23493","article-title":"Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches","volume":"93","author":"Olsen","year":"2015","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0520","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/pr.58.3.2","article-title":"The endocannabinoid system as an emerging target of pharmacotherapy","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0525","doi-asserted-by":"crossref","first-page":"11","DOI":"10.36076\/ppj\/2016.19.11","article-title":"Palmitoylethanolamide, a special food for medical purposes, in the treatment of chronic pain: a pooled data meta-analysis","volume":"19","author":"Paladini","year":"2016","journal-title":"Pain Physician"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0530","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1073\/pnas.1600251113","article-title":"Acetylcholine receptors from human muscle as pharmacological targets for ALS therapy","volume":"113","author":"Palma","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0535","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1742-2094-10-91","article-title":"A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury","volume":"10","author":"Paterniti","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0540","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.2174\/1871527313666140806124322","article-title":"Neuroprotection by association of palmitoylethanolamide with luteolin in experimental Alzheimer's disease models: the control of neuroinflammation","volume":"13","author":"Paterniti","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0545","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1093\/brain\/awl217","article-title":"Remyelination is extensive in a subset of multiple sclerosis patients","volume":"129","author":"Patrikios","year":"2006","journal-title":"Brain"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0550","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nchembio.767","article-title":"Metabolomics implicates altered sphingolipids in chronic pain of neuropathic origin","volume":"8","author":"Patti","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0555","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/imm.12163","article-title":"Oligodendrocyte-microglia cross-talk in the central nervous system","volume":"141","author":"Peferoen","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0560","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/NEN.0000000000000149","article-title":"Activation status of human microglia is dependent on lesion formation stage and remyelination in multiple sclerosis","volume":"74","author":"Peferoen","year":"2015","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0565","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/bph.13580","article-title":"The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations","volume":"174","author":"Petrosino","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0570","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3389\/fphar.2018.00249","article-title":"Oral ultramicronized palmitoylethanolamide: plasma and tissue levels and spinal anti-hyperalgesic effect","volume":"9","author":"Petrosino","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0575","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/NEN.0000000000000214","article-title":"Remyelination after cuprizone-induced demyelination is accelerated in juvenile mice","volume":"74","author":"Pfeifenbring","year":"2015","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0580","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nn.3612","article-title":"Peripheral gating of pain signals by endogenous lipid mediators","volume":"17","author":"Piomelli","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0585","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nrd.2017.115","article-title":"Remyelination therapies: a new direction and challenge in multiple sclerosis","volume":"16","author":"Plemel","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0590","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3389\/fphar.2018.00285","article-title":"Innovative nanoparticles enhance N-palmitoylethanolamide intraocular delivery","volume":"9","author":"Puglia","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0595","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nrneurol.2015.14","article-title":"Multiple sclerosis\u2014a quiet devolution","volume":"11","author":"Ransohoff","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0600","first-page":"1245","article-title":"Particle size reduction to the nanometer range: a promising approach to improve buccal absorption of poorly water-soluble drugs","volume":"6","author":"Rao","year":"2011","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1081\/PDT-120027417","article-title":"Micron-size drug particles: common and novel micronization techniques","volume":"9","author":"Rasenack","year":"2004","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0610","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1586\/14737175.6.11.1657","article-title":"Glucocorticoids in multiple scle-rosis and experimental autoimmune encephalomyelitis","volume":"6","author":"Reichardt","year":"2006","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0615","doi-asserted-by":"crossref","first-page":"14662","DOI":"10.1073\/pnas.0805640105","article-title":"The geometric and spatial constraints of the microenvironment induce oligodendrocyte differentiation","volume":"105","author":"Rosenberg","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0620","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3389\/fnagi.2017.00094","article-title":"Modulation of microglial activity by rho-kinase (ROCK) inhibition as therapeutic strategy in Parkinson's disease and amyotrophic lateral sclerosis","volume":"9","author":"Roser","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0625","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","article-title":"The orphan receptor GPR55 is a novel cannabinoid receptor","volume":"152","author":"Ryberg","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0630","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.conb.2013.09.008","article-title":"The role of myelin and oligodendrocytes in axonal energy metabolism","volume":"23","author":"Saab","year":"2013","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0635","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/2230-973X.96921","article-title":"Improvement in solubility of poor water-soluble drugs by solid dispersion","volume":"2","author":"Sareen","year":"2012","journal-title":"Int. J. Pharm. Investig."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0640","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.bbalip.2014.12.016","article-title":"Metabolism and functions of lipids in myelin","volume":"1851","author":"Schmitt","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0645","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00415-016-8341-7","article-title":"Lesion remyelinating activity of GSK239512 versus placebo in patients with relapsing-remitting multiple sclerosis: a randomised, single-blind, phase II study","volume":"264","author":"Schwartzbach","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0650","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1093\/brain\/121.12.2221","article-title":"Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis","volume":"121","author":"Scolding","year":"1998","journal-title":"Brain"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0655","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41398-017-0076-4","article-title":"Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer's disease by exerting anti-inflammatory and neuroprotective effects","volume":"8","author":"Scuderi","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0660","doi-asserted-by":"crossref","first-page":"75038","DOI":"10.18632\/oncotarget.20500","article-title":"Immethridine, histamine H3-receptor (H3R) agonist, alleviated experimental autoimmune encephalomyelitis via inhibiting the function of dendritic cells","volume":"8","author":"Shi","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0665","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1523\/JNEUROSCI.22-07-02451.2002","article-title":"The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation","volume":"22","author":"Sim","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0670","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1007\/s12035-015-9328-6","article-title":"The association of palmitoylethanolamide with luteolin decreases autophagy in spinal cord injury","volume":"53","author":"Siracusa","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0675","series-title":"A Co-Ultramicronized N-Palmitoylethanolamine\/Luteolin Composite Promotes Oligodendrocyte Precursor Cell Servival and Development and Promotes out Come in Experimental Autoimmune Encephalomyelitis. Program No. 511.16. Neuroscience Meeting Planner","author":"Skaper","year":"2016"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0680","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12035-017-0722-0","article-title":"Co-ultramicronized palmitoylethanolamide\/luteolin facilitates the development of differentiating and undifferentiated rat oligodendrocyte progenitor cells","volume":"55","author":"Skaper","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0685","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/jemt.1051","article-title":"Calcium signalling in cells of oligodendroglial lineage","volume":"52","author":"Soliven","year":"2001","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0690","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1055\/s-0036-1579739","article-title":"Immunology of multiple sclerosis","volume":"36","author":"Sospedra","year":"2016","journal-title":"Semin. Neurol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0695","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/nrneurol.2017.139","article-title":"Achievements and obstacles of remyelinating therapies in multiple sclerosis","volume":"13","author":"Stangel","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0700","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1126\/science.1230720","article-title":"Anti-inflammatory therapy in chronic disease: challenges and opportunities","volume":"166","author":"Tabas","year":"2013","journal-title":"Science"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0705","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0002-9440(10)63176-8","article-title":"Attenuation of Th1 effector cell responses and susceptibility to experimental allergic encephalomyelitis in histamine H2 receptor knockout mice is due to dysregulation of cytokine production by antigen-presenting cells","volume":"164","author":"Teuscher","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0710","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199801293380502","article-title":"Axonal transection in the lesions of multiple sclerosis","volume":"338","author":"Trapp","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0715","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.colsurfb.2016.01.058","article-title":"Nanoparticles prolong N-palmitoylethanolamide anti-inflammatory and analgesic effects in vivo","volume":"141","author":"Tronino","year":"2016","journal-title":"Colloids surf. B Biointerfaces"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0720","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/cbdv.200790159","article-title":"The N-acylethanolamine-hydrolyzing acid amidase (NAAA)","volume":"4","author":"Tsuboi","year":"2007","journal-title":"Chem. Biodivers."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0725","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1111\/febs.12152","article-title":"Metabolism of endocannabinoids and related N-acylethanolamines: canonical and alternative pathways","volume":"280","author":"Ueda","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0730","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1523\/JNEUROSCI.4311-13.2014","article-title":"Mammalian target of rapamycin promotes oligodendrocyte differentiation, initiation and extent of CNS myelination","volume":"34","author":"Wahl","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0735","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.stem.2012.12.002","article-title":"Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination","volume":"12","author":"Wang","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0740","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/archneur.1977.00500220019003","article-title":"Conduction in myelinated, unmyelinated, and demyelinated fibers","volume":"34","author":"Waxman","year":"1977","journal-title":"Arch. Neurol."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0745","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1523\/JNEUROSCI.18-02-00601.1998","article-title":"Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells","volume":"18","author":"Wolswijk","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0750","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.mcn.2003.10.014","article-title":"Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination","volume":"25","author":"Woodruff","year":"2004","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0755","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/glia.22333","article-title":"Diosgenin promotes oligodendrocyte progenitor cell differentiation through estrogen receptor-mediated ERK1\/2 activation to accelerate remyelination","volume":"60","author":"Xiao","year":"2012","journal-title":"Glia"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0760","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.brainres.2015.09.021","article-title":"The immunomodulatory oligodendrocyte","volume":"1641","author":"Zeis","year":"2016","journal-title":"Brain Res."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0765","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/glia.22643","article-title":"Adoptive transfer of cytokine-induced immunomodulatory adult microglia attenuates experimental autoimmune encephalomyelitis in DBA\/1 mice","volume":"62","author":"Zhang","year":"2014","journal-title":"Glia"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0770","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0896-6273(00)80898-3","article-title":"Identification of a novel family of oligodendrocyte lineage-specific basic helix-loop-helix transcription factors","volume":"25","author":"Zhou","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/bs.pbr.2019.03.013_bb0775","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-12529-7","article-title":"Expression and differential responsiveness of central nervous system glial cell populations to the acute phase protein serum amyloid A","volume":"7","author":"Barbierato","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0780","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40122-015-0038-6","article-title":"Palmitoylethanolamide in fibromyalgia: results from prospective and retrospective observational studies","volume":"4","author":"Del Giorno","year":"2015","journal-title":"Pain Ther."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0785","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.tins.2016.02.004","article-title":"Pushing forward: remyelination as the new frontier in CNS diseases","volume":"39","author":"Kremer","year":"2016","journal-title":"Trends Neurosci."},{"key":"10.1016\/bs.pbr.2019.03.013_bb0790","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/fsn3.392","article-title":"Safety of micronized palmitoylethanolamide (microPEA): lack of toxicity and genotoxic potential","volume":"5","author":"Nestmann","year":"2016","journal-title":"Food Sci. Nutr."}],"container-title":["Progress in Brain Research","Nanoneuroprotection and Nanoneurotoxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079612319300433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079612319300433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T12:57:22Z","timestamp":1786107442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0079612319300433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9780444642080"],"references-count":157,"URL":"https:\/\/doi.org\/10.1016\/bs.pbr.2019.03.013","relation":{},"ISSN":["0079-6123"],"issn-type":[{"value":"0079-6123","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}